以下文章来源于融中财经 ，作者王涛 融中财经 . 中国领先的股权投资与产业投资媒体平台。聚焦报道中国新经济发展和创新投资全产业链。通过全媒体资讯平台、品牌活动、研究服务、专家咨询、投资 顾问等业务，为政府、企业、投资机构提供一站式专业服务。 赴港二次上市的决策尤为迫切。 文 ｜ 王涛 编辑 ｜ 吾人 来源｜ 融中财经（ID：thecapital） 封面来源 ｜ Unsplash 继早前市场传闻中概股禾赛科技、小马智行等已以保密形式申请香港第二上市，最新又传出连锁酒店品牌亚朵正在考虑赴香港第二上市。 亚朵，是一家中国领先的生活方式集团，主要经营酒店、零售两大业务板块。根据 Frost&Sullivan 的资料，按 2024 年底的客房数量来看，亚朵为中国 最大的中高端酒店连锁。公司的酒店网络已覆盖中国 209 个城市，共计 1,619 家酒店、 183,184 间客房。 2022 年 11 月 11 日，亚朵在美国纳斯达克挂牌上市，目前其市值约 45.85 亿美元。 从西安永宁门的第一缕人文光环到纳斯达克上市资本高光，亚朵的步伐迈的很大。 五年间酒店数从 570 家激增至 1727 家， 2024 年新店 47 ...

Core Viewpoint - The return of Chinese concept stocks (Chinese companies listed in the US) to the Hong Kong market is expected to enhance the market's vibrancy and attract more international capital, thereby reinforcing Hong Kong's position as a global financial center [1][2][3]. Group 1: Market Performance and Growth - As of the first half of 2025, the market capitalization of Hong Kong has increased to HKD 42.7 trillion, representing a 33% growth compared to the previous year, with strong performance in technology stocks [1]. - In the first half of 2025, new stock financing in Hong Kong reached USD 14.1 billion, a staggering 695% increase year-on-year, significantly outpacing the global new stock financing growth of 8% [3]. Group 2: Role of Chinese Concept Stocks - Chinese concept stocks are primarily companies that are listed in the US but operate mainly in mainland China. With increasing uncertainties in the US market, these companies are seeking alternative financing platforms, with Hong Kong emerging as a favorable option [2]. - Hong Kong's geographical proximity to the Greater Bay Area, its rich service experience for mainland enterprises, and its mature financial infrastructure make it the most viable market for the return of Chinese concept stocks [2][4]. Group 3: Impact on Market Dynamics - The return of Chinese concept stocks is anticipated to invigorate the Hong Kong stock market, as these companies possess strong profitability, which is crucial for attracting investment [3][4]. - Large enterprises have a significant impact on market activity, as evidenced by the top companies in the US stock market, which account for 30% of its total market capitalization. Attracting more leading companies to Hong Kong is essential for the market's prosperity [3]. Group 4: Strategies for Return - Various strategies are being employed by large Chinese concept stocks to return to the Hong Kong market, including privatization followed by listing, dual listings, and maintaining their US listing while also listing in Hong Kong [4]. - Small and medium-sized Chinese concept stocks, which make up a significant portion of the market, also play a crucial role. Over 60% of the 286 Chinese concept stocks listed in the US have a market capitalization below USD 100 million [4]. Group 5: Opportunities for Hong Kong - The return of Chinese concept stocks presents a significant opportunity for Hong Kong to enhance its financial services for mainland manufacturing and innovation enterprises [5].

Core Viewpoint - Zhang Yong's appointment to the Hong Kong Stock Exchange's (HKEX) China Business Advisory Committee is expected to enhance the exchange's ability to optimize listing rules and attract more new economy enterprises to go public in Hong Kong [2][5]. Group 1: Zhang Yong's Background and Role - Zhang Yong, former chairman of Alibaba Group, has extensive experience in the Chinese market and financial sector, having previously held various leadership roles within Alibaba [2][3]. - His addition expands the advisory committee to nine members, which includes prominent figures from various sectors, aimed at providing insights into China's financial market dynamics [2][3]. Group 2: Impact on HKEX and Market Trends - Zhang Yong's experience is anticipated to drive further reforms at HKEX, enhancing its international competitiveness and deepening its engagement with the mainland market [5]. - The number of mainland enterprises listed on HKEX has surpassed 1,400, accounting for over 70% of the market's total market capitalization, indicating a strong trend towards new economy sectors [5]. - The "A+H" listing model is expected to see significant growth, with over 40 A-share companies planning to list in Hong Kong, and several already achieving top positions in global IPO financing [4][5]. Group 3: Future Prospects - The return of high-quality Chinese concept stocks is projected to further increase the attractiveness of the Hong Kong market, supported by regulatory encouragement from the China Securities Regulatory Commission [6].

Core Insights - The report highlights the ongoing trend of Chinese concept stocks returning to the domestic market, driven by policy guidance and market demand [5] - The healthcare sector is expected to see a revaluation opportunity as the National Healthcare Security Administration (NHSA) emphasizes anti-involution principles in drug procurement [8][10] Group 1: Strategy Research - The return of Chinese concept stocks is facilitated by a favorable regulatory environment, including the registration system and CDR (Chinese Depository Receipts) [5][6] - Various pathways for return include secondary listings in Hong Kong and privatization followed by IPOs in A-shares or Hong Kong [5][6] - The shell company market is experiencing a revaluation as demand for return increases, presenting investment opportunities [6][7] Group 2: Healthcare Sector - The NHSA has initiated the 11th batch of drug procurement, focusing on stabilizing prices and improving the procurement rules [9][10] - The previous procurement methods led to low pricing and affected profitability; however, the new measures are expected to enhance the profitability of pharmaceutical companies [9][10] - The pharmaceutical sector is gradually recovering from the impacts of procurement policies, with an optimistic outlook for revaluation as policies improve and companies' R&D efforts yield results [10]

Group 1 - The report highlights the ongoing trend of Chinese concept stocks returning to the domestic capital market due to increasing regulatory pressures and tensions in US-China relations, with the Chinese government providing supportive policies such as the registration system and CDR to facilitate this return [2][5][26] - Various pathways for the return of Chinese concept stocks are identified, including secondary listings in Hong Kong, dual primary listings, privatization followed by relisting, and CDR issuance, which collectively create a favorable environment for companies seeking to regain financing opportunities [2][37] - The report emphasizes the role of Hong Kong as a preferred destination for Chinese concept stocks due to its flexible listing mechanisms, lower thresholds, and policies allowing for "same share, different rights," making it an attractive platform for companies to return [2][5][24] Group 2 - The report discusses the benefits for Chinese securities firms from the return of Chinese concept stocks, particularly those with strong cross-border capabilities, as they can provide capital operation services and capture a larger market share [2][3][37] - The shell company market is highlighted as a key vehicle for the rapid return of Chinese concept stocks, with increased demand leading to a revaluation of shell companies, making them a focal point for investors [2][3][37] - The report outlines the integration of dual listings and the A/H share market, allowing investors to diversify their asset allocation strategies, as companies listed in both markets often exhibit cross-market premiums [2][3][37] Group 3 - The report notes that the return of Chinese concept stocks is accompanied by a potential revaluation of market capitalization and valuation premiums, indicating a shift in investor sentiment and market dynamics [2][3][37] - The report suggests that the shell market presents both opportunities and risks, necessitating effective regulation to ensure its stable and healthy development, which is crucial for the sustainable return of Chinese concept stocks [2][3][37] - The report concludes with a strategic summary advocating for a dual allocation strategy focusing on "Chinese securities firms + shell resources" to capitalize on the ongoing trends in the market [2][3][37]

Core Viewpoint - The article discusses the resurgence of the Hong Kong stock market as a global hub for IPOs, highlighting a significant increase in new listings and capital raised, positioning Hong Kong as a critical player in international finance and investment, particularly for Chinese enterprises [3][4][30]. IPO Boom - In the first half of the year, Hong Kong saw 240 companies enter the market, with 220 more in the pipeline as of June 30 [4][11]. - A total of 43 new stocks were listed, a 43.3% increase compared to the same period in 2024, raising HKD 1,067.1 billion, surpassing Nasdaq [4][10]. - The IPO of Ningde Times raised approximately HKD 357 billion, marking the largest global IPO of the year [8]. Historical Context - The article reflects on the historical evolution of Hong Kong's IPO landscape, from the early days of state-owned enterprises to the current influx of tech and consumer companies [6][14]. - The return of Chinese companies to Hong Kong, particularly in the wake of the pandemic and geopolitical tensions, has revitalized the market [4][30]. Market Dynamics - The article notes that the Hong Kong stock market has become a vital link for Chinese companies seeking international capital, with a significant portion of new listings being from mainland enterprises [4][30]. - The dominance of Chinese financial institutions in underwriting new listings is highlighted, with major players like CICC and CITIC leading the way [16][18]. Investment Trends - The influx of capital from mainland investors has increased, with southbound funds contributing HKD 730 billion, raising their market share to 43.9% [21][22]. - New consumer brands and innovative companies are capturing investor interest, with examples like Moutai and Bubble Mart showcasing unique business models that resonate with global investors [9][20]. Future Outlook - Predictions suggest that Hong Kong could see up to 80 new IPOs in 2024, raising HKD 200 billion, reinforcing its status as a leading global financial center [13][30]. - The article emphasizes the ongoing reforms in Hong Kong's financial market, including the introduction of SPACs and support for tech companies, which are expected to attract more listings and investments [30].

Core Viewpoint - Geely has signed a merger agreement to acquire all remaining shares of Zeekr, aiming to enhance synergy and growth potential in the electric vehicle market [1][2][12]. Summary by Sections Merger Agreement - Geely announced the formal signing of a merger agreement with Zeekr, intending to acquire the remaining shares not already owned [1]. - The acquisition price has been increased to $2.687 per share for Zeekr, representing a premium of over 4% compared to the previous offer [2][5]. Financial Implications - The total cost for Geely to acquire the remaining 34.3% of Zeekr shares is approximately $2.399 billion (around ¥172 billion) [5]. - If all shareholders opt for cash, Geely will need to spend about $2 billion more than the initial offer [6]. - Geely's cash reserves as of March 31, 2025, were reported at ¥35.2 billion, significantly lower than BYD's reserves [6]. Shareholder Options - Zeekr shareholders can choose between cash or exchanging their shares for Geely shares, with a conversion rate of 1.23 Geely shares for each Zeekr share [6][11]. - This provides liquidity options for Zeekr shareholders while allowing them to benefit from Geely's growth post-merger [11]. Strategic Timing - The timing of the privatization is seen as advantageous due to the trend of Chinese companies returning to the domestic market, reducing delisting risks [2][11]. Operational Integration - The merger is expected to be completed by Q4 2025, with Zeekr set to delist from the New York Stock Exchange [3]. - Post-merger, Geely plans to streamline operations and enhance internal integration, including management and organizational changes [12][17]. Market Position - Geely's sales in the first half of 2025 reached 1.932 million units, a 30% increase year-on-year, with a significant rise in new energy vehicle sales [15]. - The merger is a strategic move to reclaim the title of "self-owned vehicle leader" from BYD, with a sales target increase from 2.71 million to 3 million units [15]. Synergy and Cost Savings - The merger is projected to yield significant cost savings in R&D, procurement, and management, enhancing Geely's competitive edge [17]. - The integration aims to clarify product lines and reduce resource wastage, positioning Geely favorably for future competition [17].

Group 1 - The Hong Kong IPO market is experiencing a "V-shaped rebound" with total fundraising reaching 140 billion HKD in the first half of 2023, a 7-fold increase compared to the same period in 2022 [3] - The average first-day gain for new listings is 15.2%, significantly higher than the 9.5% from the previous year [3] - The biotechnology sector accounts for over 35% of the total IPOs, emerging as the biggest winner in the market [3] Group 2 - Three main drivers are contributing to the market recovery: 1. The trend of Chinese companies returning to Hong Kong continues, with 28 companies completing secondary listings and over 4.2 trillion HKD in market value awaiting return [5] 2. The Hong Kong Stock Exchange's regulatory innovations have attracted 18 companies to apply for listing, with optimized entry requirements for biotech firms [5] 3. International capital is being reallocated, with net inflows from southbound funds exceeding 280 billion HKD over five months, and foreign institutional holdings rising to 63% [5] Group 3 - Key investment opportunities in the second half of 2023 include sectors such as hard technology (semiconductors, AI), new energy, biomedicine (gene therapy, medical devices), and new consumption (domestic brands, cross-border e-commerce) [7] - Notable companies expected to raise significant funds include Lens Technology (5 billion HKD) as a core supplier for Apple and Kangfang Biopharmaceuticals (3 billion HKD) with its first PD-1 dual antibody [7] Group 4 - Current market conditions present an optimal window for companies to list in Hong Kong, with valuation levels up 25% compared to 2024 and a 40% increase in international investment bank participation [8] - Companies planning to go public should expedite preparations to complete listings within the year, while investors are advised to focus on IPO projects with specific characteristics [10][11]

Summary of Key Points from Conference Call Records Industry Overview - The conference call discusses the Hong Kong stock market (港股) and its relationship with the A-share market (A 股) and U.S. stock market (美股) - The analysis highlights the significant changes in capital flows, market dynamics, and the impact of Chinese companies listed in Hong Kong Core Insights and Arguments - **Increased Correlation with A-shares**: Since 2020, the correlation between the Hong Kong stock market and A-shares has significantly increased, maintaining a rolling 12-month correlation coefficient between 80% and 90%, compared to a historical average of around 60% [4][1] - **Foreign Capital Outflow**: Foreign capital has continuously flowed out of the Hong Kong market, with its share dropping from nearly 80% to 61%. Cumulative outflows have exceeded 740 billion HKD, influenced by geopolitical tensions and changes in global asset allocation [2][1] - **Impact of Currency Carry Trade**: The carry trade involving the Hong Kong dollar has intensified foreign capital outflows, as rising U.S. interest rates have widened the interest rate differential, prompting investors to borrow low-interest HKD to invest in higher-yielding assets [5][1] - **Return of Chinese Companies**: The return of Chinese companies to the Hong Kong market has improved market quality, with these companies accounting for approximately 70% of the total market capitalization. This has strengthened the correlation between the Hong Kong market and the mainland economy [6][1] - **Liquidity Boost from Southbound Capital**: Continuous inflows from southbound capital have significantly enhanced liquidity in the Hong Kong market, with annual net inflows exceeding 300 billion HKD, projected to reach over 700 billion HKD in 2024 and 2025 [8][1] - **Domestic Capital Influence**: Domestic capital has begun to dominate the Hong Kong market, with over two-thirds of market capitalization and around 91% of net profit attributable to parent companies coming from Chinese enterprises [3][10] Other Important Insights - **Market Behavior Trends**: The relationship between industry performance and southbound capital inflows shows a positive correlation, indicating that as capital flows in, market performance improves [9][1] - **Policy Support for Capital Markets**: Since 2024, various policies have been introduced to support the development of Hong Kong's capital markets, enhancing connectivity between mainland China and Hong Kong [11][1] - **Shift in Pricing Power**: The pricing power in the Hong Kong market is shifting towards domestic factors, with a significant reduction in reliance on external influences for market movements [13][1] - **Future Market Outlook**: The ongoing trends of southbound capital inflows and the concentration of quality assets are expected to play a crucial role in determining future market directions [7][1]

Group 1 - The core viewpoint of the articles highlights the strong recovery of the Hong Kong IPO market, driven by multiple factors including interest rate cuts, policy support, and improved investor sentiment [1][2][10] - As of June 18, 2025, there are over 160 companies queued for IPOs in Hong Kong, with more than 90% of these companies coming from mainland China [1][2] - The Hong Kong Stock Exchange (HKEX) has seen a significant increase in IPO activities, with a projected 40 companies expected to go public in the first half of 2025, raising approximately $14 billion, which accounts for 24% of the global total [2][3] Group 2 - The average fundraising amount for IPOs in Hong Kong has increased significantly, with a year-on-year rise of over 500%, marking the second-highest level in the past decade [2][3] - The report indicates that the biotechnology and health sectors are particularly active, with 11 IPOs each in these sectors, tying with retail and consumer industries for the highest number [2][3] - The trend of A-share listed companies seeking dual listings in Hong Kong is notable, with an average fundraising amount close to 10 billion HKD for these IPOs [3][4] Group 3 - The HKEX has implemented several policy measures to facilitate mainland companies' listings, including optimizing listing criteria for technology companies and expediting the approval process for eligible A-share companies [6][7] - The China Securities Regulatory Commission (CSRC) has introduced five measures to support leading mainland enterprises in listing in Hong Kong, enhancing the financing channels for these companies [7][8] - The influx of mainland companies into the Hong Kong market is expected to improve the overall quality and diversity of listed companies, particularly in technology and innovation sectors [5][9] Group 4 - International investors are increasingly recognizing the value of Chinese assets, with a growing trend of foreign capital flowing into the Hong Kong market [9][10] - The HKEX is enhancing its trading mechanisms and product offerings to attract international capital, including establishing offices in major global financial centers [10][11] - The outlook for the Hong Kong IPO market remains positive, with expectations of continued activity in the second half of 2025, particularly from large enterprises and technology-related sectors [10][11]